| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Tyra Biosciences, Inc.
13G/A
Amendment 3
TYRA · 90240B106
|
1.4% |
4/24/2026
Event 3/31/2026
|
|||
| Canaan XI L.P. | 1.4% | ||||
| Canaan Partners XI LLC | 1.4% | ||||
| Canaan 2020+ Co-Investment L.P. - Series 7 | 0% | ||||
| Canaan Partners 2020+ Co-Investment LLC | 0% | ||||
|
Tyra Biosciences, Inc.
13G/A
Amendment 2
TYRA · 90240B106
|
5.5% |
2/13/2026
Event 12/31/2025
|
|||
| Canaan XI L.P. | 5.5% | ||||
| Canaan Partners XI LLC | 5.5% | ||||
| Canaan 2020+ Co-Investment L.P. - Series 7 | 0.8% | ||||
| Canaan Partners 2020+ Co-Investment LLC | 0.8% | ||||
|
Aeva Technologies, Inc.
13D/A
Amendment 2
AEVA · 00835Q202
|
6.5% |
7/14/2025
Event 6/16/2025
|
|||
| Canaan XI L.P. | 6.5% | ||||
| Canaan Partners XI LLC | 6.5% | ||||
|
Tyra Biosciences, Inc.
13G/A
Amendment 1
TYRA · 90240B106
|
7.4% |
1/21/2025
Event 12/31/2024
|
|||
| Canaan XI L.P. | 7.4% | ||||
| Canaan Partners XI LLC | 7.4% | ||||
| Canaan 2020+ Co-Investment L.P. - Series 7 | 0.9% | ||||
| Canaan Partners 2020+ Co-Investment LLC | 0.9% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.